Replies to post #176362 on Vivos Inc (RDGL)

[kayak_wench]

Updating with info from 10K

The Company intends to apply for a de novo petition with an anticipated expenditure of $10.0 million over the next four years. This expenditure estimate includes anticipated costs associated with in vitro and in vivo pre-clinical testing, our application for an Investigational Device Exemption, Phase I and Phase II clinical trials and our application for a de novo petition.

So maybe plan is
- IDE approved in next 30 days,
- Mayo Clinic approves their clinical trial plan.
- IDE Clinical trial completes in 6 months to a year,
- conduct phase I and Phase II clinical trials and our application for a de novo petition over 2.5 to 3 years
- file application for de novo petition.
- routine radiogel treatment begins

[classics99]

It unlikely you will see $0.15 shares as we have built a floor around the $0.18 to 0.21 level.

I would simply accumulate in the next few weeks instead of trying to get the best price.

Every long on this board and many others will be scooping up any cheap share we can and at this point any thing under $0.20 is cheap in my mind. My average price is close to the $0.09 but as soon as I get paid again I’m buying another lot.

[classics99]

And the 18-24 months is only a timeline for the phase 1 portion of clinical trials.

[mikepgator]

If I remember the numbers correctly for the last offering, didn’t the MM’s run the price to .20 to sell… so we could be looking at a run into the 30s to sell these shares.